VENABLE LLP

Lobbying for GENEOSCOPY · Life sciences company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Missouri · House · Senate · $20,000.00 income · posted Apr 8, 2026

Lobbying activity 2

Health Issues

Increasing access to colorectal cancer screening; Medicare coverage of colorectal cancer screening tests; USPSTF colorectal cancer screening guidelines; Medicare Quality Measures; Commercial coverage of colorectal cancer screening

Budget/Appropriations

FY 2027 LHHS Appropriations regarding colorectal cancer screening

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.